Mission
SLC6A1 Connect works to raise awareness, fund scientific research, and support families affected by SLC6A1, a rare neurological condition leading to seizures and significant developmental disabilities. Their ultimate goal is to help find a cure.
Basic Information
Tax-Exempt
Founded in
2018
EIN
83-1415567
Total Assets
$2.803 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 5 goals
At a Glance
Milestones for Maxwell
A campaign focused on getting funding for treatments and research for children diagnosed with SLC6A1.
Our Kids
Meet the children affected by SLC6A1 and how your support can help them.
2024 SLC6A1 Connect International Scientific Symposium
An upcoming event focusing on research and advancements in treatments for SLC6A1.
Impact Stats
$4 million
Funds Raised
Fundraising Goal
Successfully raised funds for gene therapy research.
Over 100
Number of Attendees
International Symposium
Hosted the SLC6A1 Connect International Scientific Symposium for researchers and families.
Hundreds of mentions in national news
Media Mentions
Awareness Campaign
Launched an advocacy campaign to raise awareness for SLC6A1 disorder.
Past Events
2023 Symposium
2023-11-30
The 2023 SLC6A1 Connect Symposium was held on November 30th, 2023, right before the American Epilepsy Society Conference with researchers and families.
Upcoming Events
2024 SLC6A1 Connect International Scientific Symposium
2024-12-05
Join us for discussions on advancements in treatments for SLC6A1.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
52
56
/100
Program Expense Ratio
85.49%
16
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.04282
20
/20
Working Capital Ratio
2.803
16
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 917.6K | 97.12% |
| Program Services | 0 | 0.00% |
| Investment Income | 27.2K | 2.88% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 944.8K | 100.00% |
Related Nonprofits
Rampy Ms Research Foundation
Med Research
Disease ResearchEllyn Satter Institute Inc.
Med Research
Disease ResearchAls Therapy Development Foundation Inc.
Med Research
Disease ResearchDiabetes Research and Wellness Foundation Inc.
Med Research
Disease ResearchCystinosis Research Foundation
Med Research
Disease Research